20.07.2011 • News

Cathay Industrial Biotech Files For IPO Of Up To $200 Million

China's Cathay Industrial Biotech, the world's largest producer of biobutanol, on Tuesday filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission to raise up to $200 million in an initial public offering of American Depository Shares.

Shanghai, China-based Cathay Industrial Biotech has applied for the listing of the ADSs on the Nasdaq Global Select Market under the symbol "CBIO," the filing showed.

The company, which generated annual sales of $124.6 million in 2010, has two additional product candidates in its development pipeline: I+G, a food flavor enhancer that complements monosodium glutamate (MSG), and a bioprocess technology to produce biobutanol from cellulosic biomass feedstock. The company expects to start commercial sales of I+G by the end of the first half of 2012.

 

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.